Literature DB >> 12600221

Unit costs of inpatient hospital days.

Jan B Oostenbrink1, Tineke Buijs-Van der Woude, Michel van Agthoven, Marc A Koopmanschap, Frans F H Rutten.   

Abstract

BACKGROUND: Costs of inpatient days in hospitals are frequently the main drivers of total treatment costs, and their unit cost can markedly affect the outcomes of an economic evaluation. In many countries, the availability of unit cost data is limited and unit costs are often based on data from hospitals participating in clinical trials.
OBJECTIVE: To provide data about unit costs of inpatient hospital days in The Netherlands from a healthcare provider's perspective and to give an insight into the extent to which cost categories and total costs differ between hospitals.
DESIGN: Unit costs were collected from 22 wards and 11 intensive care units (ICUs) of general and university hospitals involved in clinical trials with 'piggybacked' economic evaluations. Direct costs, such as costs of nursing and medical materials, were calculated by dividing the annual cost per category of the nursing department by the annual number of inpatient days. Indirect costs, such as overheads and accommodation, were allocated to the nursing departments by applying direct allocation. All costs were expressed in 1998 euros (EUR).
RESULTS: The mean costs per inpatient day were EUR230 (range: EUR154-EUR311) in general hospitals and EUR323 (range: EUR209-EUR400) in university hospitals. The mean costs per inpatient day in an ICU were EUR1125 (EUR919-EUR1560). Between 38-48% of the total costs were made up of nursing costs. All cost categories showed wide variations between hospitals.
CONCLUSIONS: The results of this study were used to develop standard costs for inpatient days in The Netherlands and may contribute to the comparability and generalisability of economic evaluations.

Entities:  

Mesh:

Year:  2003        PMID: 12600221     DOI: 10.2165/00019053-200321040-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  8 in total

1.  Centre-specific or average unit costs in multi-centre studies? Some theory and simulation.

Authors:  M Raikou; A Briggs; A Gray; A McGuire
Journal:  Health Econ       Date:  2000-04       Impact factor: 3.046

2.  The economic burden of COPD.

Authors:  S D Sullivan; S D Ramsey; T A Lee
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

Review 3.  Standard cost lists for healthcare in Canada. Issues in validity and inter-provincial consolidation.

Authors:  P Jacobs; N P Roos
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

4.  NHS database of reference costs is severely flawed.

Authors:  B Ferguson
Journal:  BMJ       Date:  2001-07-14

5.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 6.  The role of perspective in defining economic measures for the evaluation of medical technology.

Authors:  A J Davidoff; N R Powe
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

7.  Hospital selection for unit cost estimates in multicentre economic evaluations. Does the choice of hospitals make a difference?

Authors:  R Goeree; A Gafni; M Hannah; T Myhr; G Blackhouse
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

8.  Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.

Authors:  M van Agthoven; E Vellenga; W E Fibbe; T Kingma; C A Uyl-de Groot
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

  8 in total
  26 in total

1.  Effectiveness of classroom based crew resource management training in the intensive care unit: study design of a controlled trial.

Authors:  Peter F Kemper; Martine de Bruijne; Cathy van Dyck; Cordula Wagner
Journal:  BMC Health Serv Res       Date:  2011-11-10       Impact factor: 2.655

Review 2.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Surgical site infection - a European perspective of incidence and economic burden.

Authors:  David J Leaper; Harry van Goor; Jacqueline Reilly; Nicola Petrosillo; Heinrich K Geiss; Antonio J Torres; Anne Berger
Journal:  Int Wound J       Date:  2004-12       Impact factor: 3.315

4.  Conceptual framework for standard economic evaluation of physical activity programs in primary prevention.

Authors:  Silke B Wolfenstetter
Journal:  Prev Sci       Date:  2011-12

Review 5.  Soft-tissue damage during total knee arthroplasty: Focus on tourniquet-induced metabolic and ionic muscle impairment.

Authors:  Constantin Mayer; Alexander Franz; Jan-Frieder Harmsen; Fina Queitsch; Michael Behringer; Johannes Beckmann; Rüdiger Krauspe; Christoph Zilkens
Journal:  J Orthop       Date:  2017-06-24

6.  Intensive care unit length of stay is reduced by protocolized family support intervention: a systematic review and meta-analysis.

Authors:  Hyun Woo Lee; Yeonkyung Park; Eun Jin Jang; Yeon Joo Lee
Journal:  Intensive Care Med       Date:  2019-07-03       Impact factor: 17.440

7.  [Cost of intensive care in a German hospital: cost-unit accounting based on the InEK matrix].

Authors:  J Martin; C Neurohr; M Bauer; M Weiss; A Schleppers
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

8.  A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency.

Authors:  C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

9.  Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trial.

Authors:  Brent C Opmeer; Kimberly R Boer; Oddeke van Ruler; Johannes B Reitsma; Hein G Gooszen; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; Cecilia M Mahler; Huug Obertop; Dirk J Gouma; Patrick Mm Bossuyt; Corianne Ajm de Borgie; Marja A Boermeester
Journal:  Crit Care       Date:  2010-05-27       Impact factor: 9.097

10.  Costs of vaginal delivery and Caesarean section at a tertiary level public hospital in Islamabad, Pakistan.

Authors:  Attia Khan; Shakila Zaman
Journal:  BMC Pregnancy Childbirth       Date:  2010-01-20       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.